| Schedule of income tax provision (benefit) |
| | | | | | | | | | | | | | | | 2025 | | 2024 | Federal: | | | | | | | Current | | $ | — | | $ | — | Deferred | | | (2,198,000) | | | 5,874,000 | | | | (2,198,000) | | | 5,874,000 | State and local: | | | | | | | Current | | | — | | | — | Deferred | | | (133,115) | | | 417,000 | | | | (133,115) | | | 417,000 | Foreign: | | | | | | | Current | | | — | | | — | Deferred | | | (724,000) | | | (11,000) | | | | (724,000) | | | (11,000) | | | | | | | | Change in valuation allowance | | | (2,371,000) | | | (6,280,000) | | | | | | | | Income tax provision (benefit) | | $ | (684,115) | | $ | — |
|
| Schedule of tax effect of these temporary differences representing deferred tax asset and liabilities |
| | | | | | | | | | | | | | | | 2025 | | 2024 | Deferred tax assets (liabilities): | | | | | | | Net operating loss carryforward | | | 21,340,000 | | | 18,463,000 | Stock-based compensation | | | 499,000 | | | 1,309,000 | Depreciation and amortization | | | 149,000 | | | 333,000 | Impairment of Intangibles | | | 241,000 | | | 222,000 | Other | | | 91,000 | | | 141,000 | Capitalized Research and Development | | | 1,726,000 | | | 1,386,000 | Lease Liability | | | 49,000 | | | 200,000 | Tax credits | | | 3,064,000 | | | 2,885,000 | Deferred tax assets | | | 27,159,000 | | | 24,939,000 | | | | | | | | Intellectual Property | | | — | | | (684,000) | ROU Asset | | | (49,000) | | | (200,000) | Deferred tax (liability) | | | (49,000) | | | (884,000) | | | | | | | | Less: Valuation allowance | | | (27,110,000) | | | (24,739,000) | Net Deferred Tax Asset / (Liability) | | | — | | | (684,000) |
|